THE ANTIBIOTIC RESISTANCE AND THE ABILITY OF BACTERIATO PRODUCE -LACTAMASES
Abstract
Background : Accessibility of bacterial patterns and their sensitivity to pus can be utilized as a thought in giving anti-microbials observationally. Vale Sorowako Inco Hospital was located in mining region where health services were not as enormous as in huge cities but can still carry out free sensitivity tests without send them to a referral hospital. Methods: Antibiotics (Penicillin, cefuroxime, Ceftriaxone, and meropenem) were tried by dise diffusion. The suspension of the test microscopic organisms was included with NaCL 0.85% until it reaches turbidity, at that point a stick sterile cotton swab of bacterial suspension on the MHA (Muller Hinton Agar) media, paper disks containing the antibiotics were put on the media and incubated for 24 hours. Results: Staphylococcus aureus, Enterobacter cloacae, Enterobacter aerogenes, Acinetobacter baumannii, Pseudomonas aeruginosa, Serratia odorifera, and Aeromonas hidropila were bacteria isolated from pus. S. aureus and E. cloacae were the most (25%). Meropenen is the most sensitive antibiotics (90%), Penicillin and Cefuroxime are the most resistance (45%). Conclusions : The resistance that happens at Vale Sorowako Inco Hospital is not due to a prescription without a culture test ask, since antibiotics given by clinicians are continuously based on a culture test, but since of the capacity of bacteria to produce b-lactamases and the the presence of genes that can code for b-lactamases which moreover cause bacteria to resistant to antibiotics.
Full Text:
PDFReferences
synergistic effects of melittin with conventional antibiotics against multidrug-resistant isolates of acinetobacter baumannii and pseudomonas aeruginosa. Microb Drug Resist 2019;25:193–202. https://doi.org/10.1089/mdr.2018.0016.
Andersen JL, He GX, Kakarla P, Ranjana KC, Kumar S, Lakra WS, et al. Multidrug efflux pumps from enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens. Int J Environ Res Public Health 2015;12:1487–547. https://doi.org/10.3390/ijerph120201487.
Bengtsson-Palme J, Larsson DGJ. Concentrations of antibiotics predicted to select for resistant bacteria: Proposed limits for environmental regulation. Environ Int 2016;86:140–9. https://doi.org/10.1016/j.envint.2015.10.015.
Breathnach AS, Riley PA, Shad S, Jownally SM, Law R, Chin PC, et al. An outbreak of wound infection in cardiac surgery patients caused by Enterobacter cloacae arising from cardioplegia ice. J Hosp Infect 2006;64:124–8. https://doi.org/10.1016/j.jhin.2006.06.015.
Balasubramanian B, Benit N, Agastian P, Almaary KS, Dawoud TM, Elbadawi YB, et al. Carbapenemases producing Klebsiella pneumoniae from the pus of hospitalized patients: In-vitro antibiotic properties of Streptomyces against multidrug resistant infectious bacteria. J Infect Public Health 2021;14:892–7. https://doi.org/10.1016/j.jiph.2021.05.006.
CLSI, “Performance standards for antimicrobial susceptibility testing,” Twentieth informational supplement, Clinical and Laboratory Standards Institute Doc. M100eS20, 2010. 2010.
Christaki E, Marcou M, Tofarides A. Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and Persistence. J Mol Evol 2020;88:26–40. https://doi.org/10.1007/s00239-019-09914-3.
Gupta M, Naik AK, Singh SK. Bacteriological profile and antimicrobial resistance patterns of burn wound infections in a tertiary care hospital. Heliyon 2019;5:e02956. https://doi.org/10.1016/j.heliyon.2019.e02956.
Huynh BT, Padget M, Garin B, Herindrainy P, Kermorvant-Duchemin E, Watier L, et al. Burden of bacterial resistance among neonatal infections in low income countries: How convincing is the epidemiological evidence? BMC Infect Dis 2015;15:127. https://doi.org/10.1186/s12879-015-0843-x.
Hernando-Amado S, Coque TM, Baquero F, Martínez JL. Defining and combating antibiotic resistance from One Health and Global Health perspectives. Nat Microbiol 2019;4:1432–42. https://doi.org/10.1038/s41564-019-0503-9.
Jamrozik E, Selgelid MJ. Surveillance and control of asymptomatic carriers of drug‐resistant bacteria. Bioethics 2019;33:766–75. https://doi.org/10.1111/bioe.12642.
Jobanputra AH, Vasait RD. Cephalosporin C acylase from Pseudomonas species: Production and enhancement of its activity by optimization of process parameters. Biocatal Agric Biotechnol 2015;4:465–70. https://doi.org/10.1016/j.bcab.2015.06.009.
Jose M. Munita. Antibiotic Resistance Mechanisms. Journeys Med Res Three Cont Over 50 Years 2017:95–9. https://doi.org/10.1142/9789813209558_0015.
Lingzhi L, Haojie G, Dan G, Hongmei M, Yang L, Mengdie J, et al. The role of two-component regulatory system in β-lactam antibiotics resistance. Microbiol Res 2018;215:126–9. https://doi.org/10.1016/j.micres.2018.07.005.
Lakshmaiah KC, Malabagi AS, Shetty R, Sinha M, Jayashree RS. Febrile Neutropenia in Hematological Malignancies: Clinical and Microbiological Profile and Outcome in High Risk Patients. J Lab Physicians 2015;7:116–20. https://doi.org/10.4103/0974-2727.163126.
Leaper D, Assadian O, Edmiston CE. Approach to chronic wound infections. Br J Dermatol 2015;173:351–8. https://doi.org/10.1111/bjd.13677.
Masi M, Winterhalter M, Pagès JM. Outer Membrane Porins. vol. 92. Springer International Publishing; 2019. https://doi.org/10.1007/978-3-030-18768-2_4.
Ministry of Health of the Republic of Indonesia. Guidelines for the Use of Antibiotics. Jakarta: Indonesia; 2011.
Mitragotri S, Burke PA, Langer R. Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies. Nat Rev Drug Discov 2014;13:655–72. https://doi.org/10.1038/nrd4363.
Martens E, Demain AL. The antibiotic resistance crisis, with a focus on the United States. J Antibiot (Tokyo) 2017;70:520–6. https://doi.org/10.1038/ja.2017.30.
Mahmoud E, Abanamy R, Binawad E, Alhatmi H, Alzammam A, Habib A, et al. Infections and patterns of antibiotic utilization in support and comfort care patients: A tertiary care center experience. J Infect Public Health 2021;14:839–44. https://doi.org/10.1016/j.jiph.2021.05.002.
Nelson K, Rubio-Aparicio D, Tsivkovski R, Sun D, Totrov M, Dudley M, et al. In Vitro Activity of the Ultra-Broad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Meropenem against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2020;64:1–31. https://doi.org/10.1128/AAC.01406-20.
O. Gutkind G, Di Conza J, Power P, Radice M. β-lactamase-mediated Resistance: A Biochemical, Epidemiological and Genetic Overview. Curr Pharm Des 2012;19:164–208. https://doi.org/10.2174/13816128130202.
Peters L, Olson L, Khu DTK, Linnros S, Le NK, Hanberger H, et al. Multiple antibiotic resistance as a risk factor for mortality and prolonged hospital stay: A cohort study among neonatal intensive care patients with hospital-acquired infections caused by gram-negative bacteria in Vietnam. PLoS One 2019;14:e0215666. https://doi.org/10.1371/journal.pone.0215666.
Sims N, Kasprzyk-Hordern B. Future perspectives of wastewater-based epidemiology: Monitoring infectious disease spread and resistance to the community level. Environ Int 2020;139:105689. https://doi.org/10.1016/j.envint.2020.105689.
Scalise A, Bianchi A, Tartaglione C, Bolletta E, Pierangeli M, Torresetti M, et al. Microenvironment and microbiology of skin wounds: The role of bacterial biofilms and related factors. Semin Vasc Surg 2015;28:151–9. https://doi.org/10.1053/j.semvascsurg.2016.01.003.
Serra R, Grande R, Butrico L, Rossi A, Settimio UF, Caroleo B, et al. Chronic wound infections: The role of Pseudomonas aeruginosa and Staphylococcus aureus. Expert Rev Anti Infect Ther 2015;13:605–13. https://doi.org/10.1586/14787210.2015.1023291.
Shen SS, Qu XY, Zhang WZ, Li J, Lv ZY. Infection against infection: Parasite antagonism against parasites, viruses and bacteria. Infect Dis Poverty 2019;8. https://doi.org/10.1186/s40249-019-0560-6.
Trojan R, Razdan L, Singh N. Antibiotic Susceptibility Patterns of Bacterial Isolates from Pus Samples in a Tertiary Care Hospital of Punjab, India. Int J Microbiol 2016;2016. https://doi.org/10.1155/2016/9302692.
Tängdén T, Giske CG. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control. J Intern Med 2015;277:501–12. https://doi.org/10.1111/joim.12342.
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 2018;18:318–27. https://doi.org/10.1016/S1473-3099(17)30753-3.
Tattersall T, Wright H, Redmond A. Meropenem-induced liver injury and beta-lactam cross-reactivity. BMJ Case Rep 2018;11:10–2. https://doi.org/10.1136/bcr-2018-227124.
Torfoss D, Fladhagen T, Holte H, Brinch L, Schjesvold FH, Fløisand Y, et al. Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial. Clin Microbiol Infect 2017;23:179–87. https://doi.org/10.1016/j.cmi.2016.10.019.
Rai S, Yadav UN, Pant ND, Yakha JK, Tripathi PP, Poudel A, et al. Bacteriological Profile and Antimicrobial Susceptibility Patterns of Bacteria Isolated from Pus/Wound Swab Samples from Children Attending a Tertiary Care Hospital in Kathmandu, Nepal. Int J Microbiol 2017;2017. https://doi.org/10.1155/2017/2529085.
Raza A, Ngieng SC, Sime FB, Cabot PJ, Roberts JA, Popat A, et al. Oral meropenem for superbugs: challenges and opportunities. Drug Discov Today 2021;26:551–60. https://doi.org/10.1016/j.drudis.2020.11.004.
Vergalli J, Bodrenko I V., Masi M, Moynié L, Acosta-Gutiérrez S, Naismith JH, et al. Porins and small-molecule translocation across the outer membrane of Gram-negative bacteria. Nat Rev Microbiol 2020;18:164–76. https://doi.org/10.1038/s41579-019-0294-2.
Zhanel GG, Lawrence CK, Adam H, Schweizer F, Zelenitsky S, Zhanel M, et al. Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations. Drugs 2018;78:65–98. https://doi.org/10.1007/s40265-017-0851-9.
Zhao H, Roistacher DM, Helmann JD. Aspartate deficiency limits peptidoglycan synthesis and sensitizes cells to antibiotics targeting cell wall synthesis in Bacillus subtilis. Mol Microbiol 2018;109:826–44. https://doi.org/10.1111/mmi.14078.
Zellweger RM, Carrique-Mas J, Thwaites GE, Baker S. The Animal/Human Interface With A Focus On Low And Middle Income Countries: Antimicrobial Resistance in Southeast Asia Report for the Department of Health and the Wellcome Trust 2016:74.
DOI: http://dx.doi.org/10.22373/pbio.v10i2.15165
DOI (PDF): http://dx.doi.org/10.22373/pbio.v10i2.15165.g7385
Refbacks
- There are currently no refbacks.
ISSN : 2828-1675
Email : official.semnasbiotik@gmail.com
Prosiding Seminar Nasional Biotik : is licensed under a Creative Commons Attribution 4.0 International License / CC BY-SA 4.0